Essential Biotechnology in the news: News From the Heartland. The Journal of the Heartland Angels

“A protein, CRR9, serves as a nexus for tumor cell survival. It’s located on the cell surface, making it an accessible drug target. By developing antibodies to the CRR9 protein, Essential Biotechnology has devised a method to kill therapy-resistant tumors.” – Jayson Kurfis

See the article here.